FDA Hearing. What FDA Failed to Disclose: 1991, 2006.
AHRP Testimony presented by Vera Sharav, December 2006. PowerPoint slides (843 kb file).
Similar Posts
How to earn promotions in pharmaceutical industry
How to earn promotions in pharmaceutical industry Tue, 6 Sep 2005 In the world of pharmaceuticals, careers are made by marketing the worst products that cause the greatest harm. Contact: Vera Hassner Sharav 212-595-8974 XenoPort Appoints Gary D. Tollefson, Former Lilly Executive, to Board Company Snapshot: XNPThttp://www.xenoport.com SANTA CLARA, Calif.,…
The FDA and Drug Safety: A Proposal for Sweeping Changes
A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH
Rolling Stone – Marketing a Phony “Miracle” Drug
“Bitter Pill” by Ben Wallace-Wells in the current issue of Rolling Stone is an excellent, informative, in-depth article providing an overview into the pharmaceutical industry’s immensely successful—albeit illegal—aggressive marketing tactics, for selling a particularly unsafe, dangerous class of drugs—the antipsychotics, Zyprexa in particular.
Measles Hysteria; FDA Approves High Risk Dengue Vaccine
For the past four-five months, the New York Times has assumed the role the lead propaganda megaphone helping government bureaucrats stir up a measles frenzy with a barrage of daily headlines. How the Measles Outbreak Started Measles Outbreak Infects 695, Highest Number Since 2000 Measles Outbreak: Yeshiva’s Preschool Program…
ADHD Drugs Induce Hallucinations in Kids–FDA safety Officers
Three years have elapsed since FDA medical officers reported the findings of their comprehensive review of clinical trial data at an FDA pediatric advisory committee hearing (March, 2006).
FDA Advisor: "Ignore breast implant vote"
FDA Advisor: “Ignore breast implant vote” Wed, 5 Nov 2003 Dr. Thomas Whalen, Chairman of FDA’s advisory committee that had voted on Nov 3 to approve with restrictions the resumption of silicone breast implants, wrote a letter to FDA Commissioner, Marc McLellan, urging him to ignore the committee’s vote and…